INCOME (LOSS) PER SHARE

12 Months Ended

Dec. 31, 2015

NOTE 15

–

INCOME (LOSS) PER SHARE

The loss and the weighted average number of shares used in computing basic and diluted loss per share for the years ended December 31, 2015, 2014 and 2013, are as follows:

	US dollars
	Year ended December 31,
	2015			2014			2013

Income (loss) for the year		(5,842,172	)		2,980,426			(9,796,853	)
Stock dividend to certain Common Stockholder		-			-			(278,263	)
Cash dividend on Series A Preferred Stock		(57,061	)		(370,441	)		(288,247	)
Stock dividend on Series B Preferred Stock		(390,219	)		(43,858	)		-
Income attributable to participating securities (Preferred Stock)		-			(596,472	)		-
Income (loss) for the period attributable to common stockholders		(6,289,452	)		1,969,655			(10,363,363	)

	Number of shares
	Year ended December 31,
	2015		2014		2013

Common shares used in computing Basic income (loss) per share		5,476, 870		5,304,500		5,325,714
Common shares used in computing Diluted income (loss) per share (*)		5,476, 870		5,349,242		5,325,714
Total weighted average number of Common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted income (loss) per share (**)		9,431,728		4,557,612		2,813,493

(*)

In applying the treasury method, the average market price of Common Stock was based on management estimate. For December 31, 2015 and 2014, management estimation considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series B Units (See Note 10C). The fair value per share of the Company’s Common Stock as of December 31, 2013 was based on the management’s estimate which was based among other factors on the closing price per share of the Company’s Common Stock on December 27, 2013, as reported on the OTCQB, which was the last reported sale of Common Stock in 2013.

(**)

The Company excludes from the calculation of diluted income (loss) per share, shares that will be issued upon the exercise of options and warrants with exercise prices, that are greater than the estimated average market value of the Company’s Common Stockand shares issuable upon conversion of Preferred Stock because their effect would be anti-dilutive. Outstanding shares that will be issued upon conversion or exercise, as applicable, of all convertible Preferred Stock, stock options and warrants, have been excluded from the calculation of the diluted net loss per share for all the reported periods for which net loss was reported because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.